» Articles » PMID: 34422324

International Expert Opinion on the Use of Nebulization for Pediatric Asthma Therapy During the COVID-19 Pandemic

Citing Articles

Diagnosis, treatment and prevention of severe acute respiratory syndrome coronavirus 2 infection in children: experts' consensus statement updated for the Omicron variant.

Jiang R, Xie Z, Jiang Y, Lu X, Jin R, Zheng Y World J Pediatr. 2023; 20(3):272-286.

PMID: 37676610 DOI: 10.1007/s12519-023-00745-3.

References
1.
Taille C, Chenivesse C, Devouassoux G, Bourdin A, Garcia G . Management of asthma during the Coronavirus disease 2019 outbreak. Respir Med Res. 2020; 78:100762. PMC: 7247471. DOI: 10.1016/j.resmer.2020.100762. View

2.
Alexander L, Carson J, McCaughan J, Moore J, Millar B . Thinking inside the box: nebulizer care, safe storage, and risk of infection in cystic fibrosis. J Bras Pneumol. 2020; 46(2):e20190226. PMC: 7462698. DOI: 10.36416/1806-3756/e20190226. View

3.
Benge C, Barwise J . Aerosolization of COVID-19 and Contamination Risks During Respiratory Treatments. Fed Pract. 2020; 37(4):160-163. PMC: 7173638. View

4.
Brough H, Kalayci O, Sediva A, Untersmayr E, Munblit D, Rodriguez Del Rio P . Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - The 2020 COVID-19 pandemic: A statement from the EAACI-section on pediatrics. Pediatr Allergy Immunol. 2020; 31(5):442-448. PMC: 7264548. DOI: 10.1111/pai.13262. View

5.
Welch M . Nebulization therapy for asthma: a practical guide for the busy pediatrician. Clin Pediatr (Phila). 2008; 47(8):744-56. DOI: 10.1177/0009922808316188. View